Isradipine
Back to searchMolecule Structure
Scientific Name
Isradipine
Description of the Drug
Isradipine is a dihydropyridine calcium channel blocker used for the treatment of hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00270
http://www.drugbank.ca/drugs/DB00270
Brand Name(s)
Dynacirc, Dynacirc cr, Isradipine, Prescal
Company Owner(s)
Smithkline Beecham Corp Dba Glaxosmithkline, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Elite Laboratories Inc, Mylan Pharmaceuticals Inc, Glaxosmithkline Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Voltage-gated L-type calcium channel | PROTEIN FAMILY | BLOCKER | CHEMBL2095229 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34555 | ||
PharmGKB | PA450131 | ||
Human Metabolome Database | HMDB0014415 | ||
DrugBank | DB00270 | ||
PubChem: Thomson Pharma | 14804055 | ||
PubChem | 3784 | ||
LINCS | LSM-1897 | ||
Nikkaji | J33.142B | J356.393F | J356.392H |
BindingDB | 50436176 | ||
EPA CompTox Dashboard | DTXSID4023179 | ||
DrugCentral | 1511 | ||
Brenda | 196830 | ||
ChemicalBook | CB2268682 | ||
Guide to Pharmacology | 4488 | ||
rxnorm | ISRADIPINE | ||
PubChem: Drugs of the Future | 12013580 | ||
ChEBI | 6073 |